Horstkotte v. NHDOC, et al.

2009 DNH 190
CourtDistrict Court, D. New Hampshire
DecidedDecember 11, 2009
DocketCV-08-61-JL
StatusPublished
Cited by1 cases

This text of 2009 DNH 190 (Horstkotte v. NHDOC, et al.) is published on Counsel Stack Legal Research, covering District Court, D. New Hampshire primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Horstkotte v. NHDOC, et al., 2009 DNH 190 (D.N.H. 2009).

Opinion

Horstkotte v. NHDOC, et al. CV-08-61-JL 12/11/09 UNITED STATES DISTRICT COURT DISTRICT OF NEW HAMPSHIRE

Todd M. Horstkotte

v. Civil No. 08-CV-61-JL Opinion No. 2009 DNH 190 Commissioner, New Hampshire Department of Corrections, et al.

OPINION AND ORDER

This case concerns whether a prison provided adequate

medical care to an inmate in the early stages of hepatitis C.

Plaintiff Todd Horstkotte, formerly an inmate at the New

Hampshire State Prison, has sued various prison officials and

staff members alleging that they failed to provide adequate care

for his disease. He asserts an Eighth Amendment civil rights

claim under 42 U.S.C. § 1983, a discrimination claim under the

Americans with Disabilities Act ("ADA"), 42 U.S.C. § 12132, and

state-law claims for negligence, medical malpractice, and

intentional infliction of emotional distress.1 This court has

jurisdiction under 28 U.S.C. §§ 1331 (federal question) and 1367

(supplemental jurisdiction).

Earlier in the case, this court denied Horstkotte's request

for preliminary injunctive relief, finding that he was unlikely

1Horstkotte also asserted a number of other claims that this court previously dismissed on the merits, as recommended by Judge Muirhead without objection from Horstkotte. Document nos. 4 (Muirhead, M.J.) and 24. to succeed on the merits.2 The defendants have now moved for

summary judgment, see Fed. R. Civ. P. 56, making substantially

the same arguments that they made at the preliminary stage.

Horstkotte, who is proceeding pro se, has not objected. After

reviewing the summary judgment record, this court grants the

motion. While Horstkotte may have preferred a more aggressive

approach to his hepatitis C infection, the defendants have shown

that they provided adeguate medical care based on legitimate

medical considerations.

I. Applicable legal standard

Summary judgment is appropriate where "the pleadings, the

discovery and disclosure materials on file, and any affidavits

show that there is no genuine issue as to any material fact and

that the movant is entitled to a judgment as a matter of law."

Fed. R. Civ. P. 56(c). An issue is "genuine" if it may

reasonably be resolved in either party's favor at trial, and

"material" if it has the capacity to sway the outcome under

applicable law. Vineberg v. Bissonnette, 548 F.3d 50, 56 (1st

Cir. 2008) (guotations omitted). In making this determination,

the "court must scrutinize the record in the light most

flattering to the party opposing the motion, indulging all

2Document nos. 57 (Muirhead, M.J.) and 63.

2 reasonable inferences in that party's favor." Mulvihill v. Top-

Flite Golf C o ., 335 F.3d 15, 19 (1st Cir. 2003).

Where, as here, the non-moving party files no response to

the summary judgment motion, "[a]11 properly supported material

facts in the moving party's factual statement shall be deemed

admitted," since they were not "properly opposed." L.R.

7.2(b)(2); see also De Jesus v. LTT Card Svcs., Inc., 474 F.3d

16, 20 (1st Cir. 2007). Summary judgment does not, however,

"automatically follow." Stonkus v. City of Brockton Sch. Dep't,

322 F.3d 97, 102 (1st Cir. 2003). The court still must evaluate

whether the moving party's submission meets the summary judgment

standard. See Fed. R. Civ. P. 56(e) ("If the adverse party does

not . . . respond, summary judgment, if appropriate, shall be

entered against the adverse party.") (emphasis added).

Consistent with this approach, the following background summary

is based on the defendants' factual statement, which is supported

by affidavits, medical records, and testimony from the

preliminary injunction hearing.

II. Background

Horstkotte arrived at the New Hampshire State Prison in June

2007 to begin serving a prison sentence with a three-year

maximum. As part of the routine intake process, he underwent a

3 medical exam and blood tests. The tests revealed an elevated

liver enzyme level, most commonly associated with the hepatitis C

virus. Further testing confirmed the presence of the virus.

Because Horstkotte had tested negative for the virus in June 2005

and had a normal liver enzyme level in November 2005, the

prison's chief medical officer--defendant Dr. Celia Englander3--

concluded that he must have contracted the disease within the

preceding year-and-a-half. Horstkotte agrees with that

conclusion.

After the diagnosis. Dr. Englander evaluated whether

Horstkotte was an appropriate candidate for hepatitis C

treatment. The treatment involves a combination of two drugs

(ribavirin and pegylated interferon) that can have serious side

effects. Under prison protocol, an inmate is eligible for

treatment only if his minimum sentence is long enough to complete

the entire treatment process, which takes at least two-and-a-half

years (including one year of assessment, one year of drug

therapy, and six months of follow-up care). This reguirement is

based on a medical concern that incomplete or interrupted

treatment could lead to drug resistance or other adverse effects.

Since Horstkotte's minimum parole date was only six months away

3Dr. Englander is a board-certified physician who has been practicing medicine for 25 years and has significant experience with hepatitis C patients.

4 (in January 2008), Dr. Englander deemed him ineligible for

treatment under the protocol.

The prison allows its medical staff to depart from the

protocol where medically necessary to treat inmates at advanced

stages of hepatitis C. But Dr. Englander concluded that no

departure was medically necessary in Horstkotte's case because he

was at a very early stage of the disease and not suffering any

symptoms.4 Hepatitis C is a slow-moving disease that can take

decades to progress to the point where it creates serious health

problems reguiring treatment. In some cases, the disease never

reaches that point because the body's natural immune response

suppresses or even eliminates it. Dr. Englander relied on

materials from the National Institutes of Health and other

sources indicating that drug combination therapy generally is not

recommended in the early stages of the disease, given the

potential side effects and the possibility of natural

suppression. She saw no significant threat to Horstkotte's

health from waiting to see how his immune system responded.

Horstkotte, who wanted to take a more aggressive approach,

reguested a liver biopsy. Dr. Englander considered the biopsy

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Horstkotte v. NH Dept. of Corrections
2010 DNH 058 (D. New Hampshire, 2010)

Cite This Page — Counsel Stack

Bluebook (online)
2009 DNH 190, Counsel Stack Legal Research, https://law.counselstack.com/opinion/horstkotte-v-nhdoc-et-al-nhd-2009.